{"title":"Generation of T Cell Receptor Retrogenic Mice","authors":"Yuelin Kong, Yi Jing, Maria Bettini","doi":"10.1002/cpim.76","DOIUrl":null,"url":null,"abstract":"<p>The ability to express and study a single T cell receptor (TCR) <i>in vivo</i> is an important aspect of both basic and translational immunological research. Traditionally, this was achieved by using TCR transgenic mice. In the past decade, a more efficient approach for single TCR expression was developed. This relatively rapid and accessible method utilizes retrovirus-mediated stem cell–based gene transfer and is commonly referred to as the TCR retrogenic approach. In this approach, hematopoietic bone marrow precursors are transduced with retroviral vector carrying both alpha and beta chains of a T cell receptor. After successful transduction, bone marrow is injected into recipient mice, in which T cell development is driven by expression of the vector-encoded TCR. This article details the materials and methods required to generate TCR retrogenic mice. It is divided into three sections and provides detailed methods for generation of stable retroviral producer cell lines, isolation and optimal transduction of hematopoietic bone marrow cells, and subsequent analysis of TCR retrogenic T cells. A detailed example of such analysis is provided. The current protocol is a culmination of many years of optimization and is the most efficient approach to date. Bone marrow transduction and transfer into recipient mice can now be achieved in a short period of four days. The protocol can be followed in most laboratories with standard biomedical equipment, and is supported by a troubleshooting guide that covers potential pitfalls and unexpected results. © 2019 by John Wiley & Sons, Inc.</p>","PeriodicalId":10733,"journal":{"name":"Current Protocols in Immunology","volume":"125 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpim.76","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Immunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpim.76","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 2
Abstract
The ability to express and study a single T cell receptor (TCR) in vivo is an important aspect of both basic and translational immunological research. Traditionally, this was achieved by using TCR transgenic mice. In the past decade, a more efficient approach for single TCR expression was developed. This relatively rapid and accessible method utilizes retrovirus-mediated stem cell–based gene transfer and is commonly referred to as the TCR retrogenic approach. In this approach, hematopoietic bone marrow precursors are transduced with retroviral vector carrying both alpha and beta chains of a T cell receptor. After successful transduction, bone marrow is injected into recipient mice, in which T cell development is driven by expression of the vector-encoded TCR. This article details the materials and methods required to generate TCR retrogenic mice. It is divided into three sections and provides detailed methods for generation of stable retroviral producer cell lines, isolation and optimal transduction of hematopoietic bone marrow cells, and subsequent analysis of TCR retrogenic T cells. A detailed example of such analysis is provided. The current protocol is a culmination of many years of optimization and is the most efficient approach to date. Bone marrow transduction and transfer into recipient mice can now be achieved in a short period of four days. The protocol can be followed in most laboratories with standard biomedical equipment, and is supported by a troubleshooting guide that covers potential pitfalls and unexpected results. © 2019 by John Wiley & Sons, Inc.
T细胞受体逆转录小鼠的产生
在体内表达和研究单个T细胞受体(TCR)的能力是基础和转化免疫学研究的一个重要方面。传统上,这是通过使用TCR转基因小鼠来实现的。在过去的十年中,一种更有效的TCR表达方法被开发出来。这种相对快速和容易获得的方法利用逆转录病毒介导的干细胞基因转移,通常被称为TCR逆转录方法。在这种方法中,造血骨髓前体被携带T细胞受体α和β链的逆转录病毒载体转导。成功转导后,将骨髓注射到受体小鼠中,其中T细胞的发育由载体编码的TCR的表达驱动。本文详细介绍了制备TCR逆转录小鼠所需的材料和方法。本文分为三个部分,详细介绍了稳定的逆转录病毒产生细胞系的生成、造血骨髓细胞的分离和最佳转导以及TCR逆转录T细胞的后续分析方法。本文提供了这种分析的一个详细示例。目前的协议是多年优化的结果,是迄今为止最有效的方法。骨髓转导和移植到受体小鼠体内现在可以在四天的短时间内完成。该方案可在大多数具有标准生物医学设备的实验室中遵循,并附有涵盖潜在陷阱和意外结果的故障排除指南。©2019 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。